Description

ABSTRACT
Aim: Pulmonary embolism (PE) is defined as a sudden total or partial obliteration of the trunk of the pulmonary artery or one of its branches. It is a frequent and serious emergency. We carried out this work with the aim of analyzing the therapeutic and evolutionary aspects of pulmonary embolism in the cardiology department of the University Hospital of Kati.
Methods: A descriptive retrospective study was carried out from January 2019 to December 2020. The inclusion criteria were patients hospitalized for pulmonary embolism based on clinical and CT angiography criteria. The variables studied were: age, sex, clinical and paraclinical signs (pulmonary CT scan), treatment and evolution.
Results: A total of 32 patients were examined out of 189 patients hospitalized in the department, either a prevalence of 17%, the female sex predominated (53.1%), either a sex ratio of 0.88. The 41 to 60 age group was the most represented, at 40.6%. Dyspnea with 96.9% and tachycardia with 68.8%, were the clinical signs most found on physical examination. Bilateral occlusion (62.5%) followed by unilateral occlusion (25%) were the most observed CT abnormalities. The main drugs used were: low molecular weight heparin in 96.9% of cases, sintrom in 50% of cases and previscan in 46.9% of cases. The outcome was favorable in the majority of patients, either 71.9%, however some complications were observed: pneumonia in 9.4% of cases, heart failure 6.3% of cases with a total mortality of 9.4%.
Conclusion: Pulmonary embolism is a serious and frequent pathology, the female sex and young people are the most affected in our environment. Early and adequate management is necessary to obtain a favorable outcome.
Key words: Pulmonary Embolism, Therapeutic, Evolution, CHU Kati